Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ksenia Magidey"'
Autor:
Michael Timaner, Ziv Raviv, Shai Shen-Orr, Yuval Shaked, Tongwu Zhang, Ksenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, Rachelly Normand, Brian P. James, Roi Gazit, Ze'ev A. Ronai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Metastasis is the major cause of death in patients with cancer. Myeloid skewing of hematopoietic cells is a prominent promoter of metastasis. However, the reservoir of these cells in the bone marrow (BM) compartment and their differentiati
Externí odkaz:
https://doaj.org/article/b1eb6c9ab4594ba7bc4b1dc99865ddec
Autor:
Michael Timaner, Ziv Raviv, Shai Shen-Orr, Yuval Shaked, Tongwu Zhang, Ksenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, Rachelly Normand, Brian P. James, Roi Gazit, Ze'ev A. Ronai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Externí odkaz:
https://doaj.org/article/d52b571268c14be3a4db3fc9ccc60dcd
Autor:
Yuval Shaked, Ron N. Apte, Elena Voronov, Marina Bersudsky, Noa Lavi, Michal Hayun, Shimrit Avraham, Michael Timaner, Yael Cohen, Irit Avivi, Noga Barak, Anat Reiner-Benaim, Ksenia Magidey, Ofrat Beyar-Katz
Multiple myeloma (MM) is a plasma cell neoplasia commonly treated with proteasome inhibitors such as bortezomib. Although bortezomib has demonstrated enhanced survival benefit, some patients relapse and subsequently develop resistance to such therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18c6c7c64a0ed62df3c722c385ba35f2
https://doi.org/10.1158/1541-7786.c.6541101
https://doi.org/10.1158/1541-7786.c.6541101
Autor:
Yuval Shaked, Ron N. Apte, Elena Voronov, Marina Bersudsky, Noa Lavi, Michal Hayun, Shimrit Avraham, Michael Timaner, Yael Cohen, Irit Avivi, Noga Barak, Anat Reiner-Benaim, Ksenia Magidey, Ofrat Beyar-Katz
Figure S1. Bone marrow-derived macrophages enrich MM TICs. Figure S2. IL-1β promotes MM-TIC enrichment. Figure S3. Reduced survival in MM patients with high levels of M1 pro-inflammatory macrophages and TICs. Table S1: Patient characteristics and tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46aa6d8376fed290c5d6a754f5bf3903
https://doi.org/10.1158/1541-7786.22515483
https://doi.org/10.1158/1541-7786.22515483
Autor:
Robert S. Kerbel, David Andrews, Valeria Miller, Florence T.H. Wu, Shan Man, Ping Xu, Ofrat Beyar-Katz, Ksenia Magidey, Santosh Hariharan, Elizabeth Pham, Yuval Shaked
Levels of viable CEPs in the blood of Balb/c mice treated with escalating doses of capecitabine (S1); A flow chart of the image analysis (S2); Colonization of bone marrow derived cells in tumors from mice treated with LDM or MTD capecitabine regimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dfda9d11d2091162a882ef8579babd8
https://doi.org/10.1158/0008-5472.22411463
https://doi.org/10.1158/0008-5472.22411463
Autor:
Robert S. Kerbel, David Andrews, Valeria Miller, Florence T.H. Wu, Shan Man, Ping Xu, Ofrat Beyar-Katz, Ksenia Magidey, Santosh Hariharan, Elizabeth Pham, Yuval Shaked
Panel of antibodies used for the mass cytometry assay (S1); Surface markers associated with metastasis (S2); Features extracted for each colony (S3).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b050adbb9fb1b5859cb0edaf35b42c
https://doi.org/10.1158/0008-5472.22411457.v1
https://doi.org/10.1158/0008-5472.22411457.v1
Autor:
Robert S. Kerbel, David Andrews, Valeria Miller, Florence T.H. Wu, Shan Man, Ping Xu, Ofrat Beyar-Katz, Ksenia Magidey, Santosh Hariharan, Elizabeth Pham, Yuval Shaked
Conventional chemotherapy drugs administered at a maximum tolerated dose (MTD) remains the backbone for treating most cancers. Low-dose metronomic (LDM) chemotherapy, which utilizes lower, less toxic, doses given on a close regular basis over prolong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::607a2d783b608acc25f1480a39ef2f9a
https://doi.org/10.1158/0008-5472.c.6508229.v1
https://doi.org/10.1158/0008-5472.c.6508229.v1
Autor:
Robert S. Kerbel, David Andrews, Valeria Miller, Florence T.H. Wu, Shan Man, Ping Xu, Ofrat Beyar-Katz, Ksenia Magidey, Santosh Hariharan, Elizabeth Pham, Yuval Shaked
Materials and Methods used in the supplemental information including flow cytometry, viable CEP levels, colony forming assay, and tissue immunostaining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16b3e6c3a832423e8491bc70d4b07430
https://doi.org/10.1158/0008-5472.22411460.v1
https://doi.org/10.1158/0008-5472.22411460.v1
Autor:
Shimrit Avraham, Marina Bersudsky, Irit Avivi, Yael Cohen, Michal Hayun, Noga Barak, Michael Timaner, Noa Lavi, Elena Voronov, Ron N. Apte, Yuval Shaked, Ofrat Beyar-Katz, Ksenia Magidey, Anat Reiner-Benaim
Publikováno v:
Molecular Cancer Research
Multiple myeloma (MM) is a plasma cell neoplasia commonly treated with proteasome inhibitors such as bortezomib. Although bortezomib has demonstrated enhanced survival benefit, some patients relapse and subsequently develop resistance to such therapy
Autor:
Ksenia Magidey-Klein, Tim J Cooper, Michael Timaner, Roi Gazit, Ziv Raviv, Ze'ev Ronai, Brian P. James, Yuval Shaked, Ksenya Kveler, Tongwu Zhang, Shai S. Shen-Orr, Rachelly Normand
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundMetastasis is the major cause of death in patients with cancer. Myeloid skewing of hematopoietic cells is a prominent promoter of metastasis. However, the reservoir of these cells in the bone marrow (BM) compartment and their differentiatio